![](/img/cover-not-exists.png)
SAFIR cohort: One-year prospective follow-up of very old and frail patients treated with direct oral anticoagulant, rivaroxaban
Hanon, O., Chaussade, E., David, J.P., Boulloche, N., Vinsonneau, U., Fauchier, L., Krolak-Salmon, P., Jouanny, P., Sacco, G., Lilamand, M., Paillaud, E., Guerin, O., Bonnefoy, M., Mahe, I., Toulza, OVolume:
12
Language:
english
Journal:
Archives of Cardiovascular Diseases Supplements
DOI:
10.1016/j.acvdsp.2019.09.250
Date:
January, 2020
File:
PDF, 236 KB
english, 2020